With the ageing population, the incidence rate of cutaneous squamous cell carcinoma
(cSCC) increases steeply in older adult population [
[1]
]. This evidence poses important management challenges, due to older adult patients'
clinical complexity, including comorbidities, cognitive impairment, and social issues.
In this context, definitive radiotherapy (RT) represents a powerful single option
in the local treatment of cSCC, although its optimal scheme remains controversial.
We presented an analysis of retrospective cohort investigating the role of weekly
hypofractionated RT in older adult patients with cSCC.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Geriatric OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer statistics, 2020.CA Cancer J. Clin. 2021; 7: 7-33
- Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region.Radiol. Med. 2021; 126: 620-622
- Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: executive summary of an American Society for Radiation Oncology clinical practice guideline.Pract. Radiat. Oncol. 2020; 10: 8-20
- Sequencing and combination of systemic therapy in metastatic renal cell carcinoma.Eur. Urol. Oncol. 2019; 2: 505-514
- Neoadjuvant-intensified treatment for rectal cancer: time to change?.World J. Gastroenterol. 2013; 19: 3052-3061
- Major clinical research advances in gynecologic cancer in 2020.J. Gynecol. Oncol. 2021; 32e53
- Cemiplimab.First Global Approval. Drugs. 2018; 78: 1841-1846
- Libtayo (Cemiplimab).(Available on line:) (Accessed: June 1, 2021)
Article info
Publication history
Published online: September 15, 2021
Accepted:
September 7,
2021
Received in revised form:
August 28,
2021
Received:
June 14,
2021
Identification
Copyright
© 2021 Elsevier Ltd. All rights reserved.
